Royalty Pharma Plc (RPRX)
39.72
+0.63
(+1.61%)
USD |
NASDAQ |
Jan 21, 16:00
39.92
+0.20
(+0.50%)
After-Hours: 20:00
Royalty Pharma EPS Diluted (Quarterly): 0.6654 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Denali Therapeutics, Inc. | -0.736 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
| Amgen, Inc. | 5.934 |
| PTC Therapeutics, Inc. | 0.195 |
| Zenas BioPharma, Inc. | -1.222 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 444.21M |
| Revenue (Quarterly) | 609.29M |
| Total Expenses (Quarterly) | 321.07M |
| Enterprise Value | 28.18B |
| Gross Profit Margin (Quarterly) | 99.79% |
| Profit Margin (Quarterly) | 72.91% |
| Earnings Yield | 4.40% |
| Operating Earnings Yield | 6.74% |
| Normalized Earnings Yield | 4.624 |